Fundraising Fox

Gameto

Austin, US · Founded 2020 · Delaware corporation · 18 known investors

gametogen.com

Gameto develops cell therapy and reproductive technologies to treat infertility and improve women's health outcomes. The company uses stem cell biology and in vitro maturation techniques to create innovative solutions for patients seeking family-building options.

BiotechFemTechHealthtechMedical Devices

Founders & leadership

Gameto was founded in 2020 by Dina Turner, Martin Varsavsky, and Dina Radenkovic.

DTDina Turner
Dina Turnerin𝕏Co-founder & Chief Executive Officer
MVMartin Varsavsky
Martin Varsavskyin𝕏Co-founder & ChairmanGeneral Partner at Myelin VC
DRDina Radenkovic
Dina RadenkovicCo-founder30 Under 30 2023

Board

DPDusan Perovic
Dusan Perovicin𝕏Board MemberPartner at Two Sigma Ventures
DM
Dylan MorrisBoard director
MSMaryanna Saenko
Maryanna Saenkoin𝕏Board directorCo-founder at Future Ventures

Investors · 18

Reported raises · per SEC filings

Form D private placements

$123.6M disclosed across 4 rounds · 2021–2025

$44MraisedAug 2025 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Martin VarsavskyExecutive Officer, Director
  • Dina RadenkovicExecutive Officer, Director
  • Maryanna SaenkoDirector
  • Kristina SimmonsDirector
  • Dusan PerovicDirector
  • Jonathan HostensDirector
Offering amount
$44M
Amount sold
$44M
First sale
Jul 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$43MraisedMay 2024 · 26 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Martin VarsavskyExecutive Officer, Director
  • Dusan PerovicDirector
  • Dina RadenkovicExecutive Officer, Director
  • Dylan MorrisDirector
  • Maryanna SaenkoDirector
Offering amount
$43M
Amount sold
$43M
First sale
May 2024
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$9.6MraisedSep 2022 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Maryanna SaenkoDirector
  • Dylan MorrisDirector
  • Martin VarsavskyDirector
  • Dina RadenkovicExecutive Officer
Offering amount
$10M
Amount sold
$9.6M
First sale
Jun 2022
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$27MraisedSep 2022 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dina RadenkovicExecutive Officer
  • Martin VarsavskyDirector
  • Maryanna SaenkoDirector
  • Dylan MorrisDirector
Offering amount
$27M
Amount sold
$27M
First sale
Dec 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Companies competing with Gameto for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does Gameto do?
Gameto develops cell therapy and reproductive technologies to treat infertility and improve women's health outcomes. The company uses stem cell biology and in vitro maturation techniques to create innovative solutions for patients seeking family-building options.
Who founded Gameto?
Gameto was founded by Dina Turner, Martin Varsavsky, Dina Radenkovic in 2020.
Who are Gameto's investors?
Gameto's investors include Bold Capital Partners, Future Ventures, Ingeborg Investments, Jazzya Investments, Korify Capital, Lux Capital, Myelin VC, Overwater Ventures Llc and 10 more.
How much funding has Gameto raised?
Gameto has disclosed $123.6M raised across 4 rounds.
Where is Gameto headquartered?
Gameto is headquartered in Austin, US.